Literature DB >> 23033371

Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.

Scott L Hummel1, E Mitchell Seymour, Robert D Brook, Theodore J Kolias, Samar S Sheth, Hannah R Rosenblum, Joanna M Wells, Alan B Weder.   

Abstract

Recent studies suggest that oxidative stress and vascular dysfunction contribute to heart failure with preserved ejection fraction (HFPEF). In salt-sensitive HFPEF animal models, diets low in sodium and high in potassium, calcium, magnesium, and antioxidants attenuate oxidative stress and cardiovascular damage. We hypothesized that the sodium-restricted Dietary Approaches to Stop Hypertension diet (DASH/SRD) would have similar effects in human hypertensive HFPEF. Thirteen patients with treated hypertension and compensated HFPEF consumed the DASH/SRD for 21 days (all food/most beverages provided). The DASH/SRD reduced clinic systolic (155-138 mm Hg; P=0.02) and diastolic blood pressure (79-72 mm Hg; P=0.04), 24-hour ambulatory systolic (130-123 mm Hg; P=0.02) and diastolic blood pressure (67-62 mm Hg; P=0.02), and carotid-femoral pulse wave velocity (12.4-11.0 m/s; P=0.03). Urinary F2-isoprostanes decreased by 31% (209-144 pmol/mmol Cr; P=0.02) despite increased urinary aldosterone excretion. The reduction in urinary F2-isoprostanes closely correlated with the reduction in urinary sodium excretion on the DASH/SRD. In this cohort of HFPEF patients with treated hypertension, the DASH/SRD reduced systemic blood pressure, arterial stiffness, and oxidative stress. These findings are characteristic of salt-sensitive hypertension, a phenotype present in many HFPEF animal models and suggest shared pathophysiological mechanisms linking these 2 conditions. Further dietary modification studies could provide insights into the development and progression of hypertensive HFPEF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033371      PMCID: PMC3522520          DOI: 10.1161/HYPERTENSIONAHA.112.202705

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Endothelial cell activation in patients with decompensated heart failure.

Authors:  Paolo C Colombo; Javier E Banchs; Sulejman Celaj; Ashok Talreja; Justine Lachmann; Shailesh Malla; Nicholas B DuBois; Anthony W Ashton; Farhana Latif; Ulrich P Jorde; J Anthony Ware; Thierry H LeJemtel
Journal:  Circulation       Date:  2004-12-20       Impact factor: 29.690

2.  Effect of salt on isoprostanes in salt-sensitive essential hypertension.

Authors:  Cheryl L Laffer; Rodney J Bolterman; Juan Carlos Romero; Fernando Elijovich
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

3.  Low-renin (volume dependent) mild-hypertensive patients have impaired flow-mediated and glyceryl-trinitrate stimulated vascular reactivity.

Authors:  Juan Carlos Yugar-Toledo; Lúcia Helena Bonalume Tácito; Sílvia Elaine Ferreira-Melo; Walnéia Sousa; Fernanda Consolin-Colombo; Maria Cláudia Irigoyen; Kléber Franchini; Otávio Rizzi Coelho; Heitor Moreno
Journal:  Circ J       Date:  2005-11       Impact factor: 2.993

4.  One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants.

Authors:  Jamy D Ard; Cynthia J Coffman; Pao-Hwa Lin; Laura P Svetkey
Journal:  Am J Hypertens       Date:  2004-12       Impact factor: 2.689

5.  Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group.

Authors:  T J Moore; W M Vollmer; L J Appel; F M Sacks; L P Svetkey; T M Vogt; P R Conlin; D G Simons-Morton; L Carter-Edwards; D W Harsha
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

6.  Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder.

Authors:  Hiromitsu Matsui; Katsuyuki Ando; Hiroo Kawarazaki; Ai Nagae; Megumi Fujita; Tatsuo Shimosawa; Miki Nagase; Toshiro Fujita
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

7.  Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension.

Authors:  E M Seymour; Andrew A M Singer; Maurice R Bennink; Rushi V Parikh; Ara Kirakosyan; Peter B Kaufman; Steven F Bolling
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

8.  Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?

Authors:  Salvatore Paterna; Parrinello Gaspare; Sergio Fasullo; Filippo M Sarullo; Pietro Di Pasquale
Journal:  Clin Sci (Lond)       Date:  2008-02       Impact factor: 6.124

9.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

Review 10.  Salt sensitivity of blood pressure in humans.

Authors:  M H Weinberger
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  60 in total

1.  Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GOURMET-HF).

Authors:  Jeffrey D Wessler; Mathew S Maurer; Scott L Hummel
Journal:  Am Heart J       Date:  2015-01-07       Impact factor: 4.749

2.  Longitudinal Change of Perceived Salt Intake and Stroke Risk in a Chinese Population.

Authors:  Yun Li; Zhe Huang; Cheng Jin; Aijun Xing; Yesong Liu; Chunmei Huangfu; Alice H Lichtenstein; Katherine L Tucker; Shouling Wu; Xiang Gao
Journal:  Stroke       Date:  2018-05-08       Impact factor: 7.914

Review 3.  Nutritional Interventions in Heart Failure: Challenges and Opportunities.

Authors:  Conor P Kerley
Journal:  Curr Heart Fail Rep       Date:  2018-06

4.  Arterial stiffness and hypertension.

Authors:  Gary F Mitchell
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

Review 5.  Stress and salt sensitivity in primary hypertension.

Authors:  Deborah L Stewart; Gregory A Harshfield; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

6.  Plasma levels of natriuretic peptides and year-by-year blood pressure variability: a population-based study.

Authors:  J Kato; Y Kawagoe; D Jiang; K Kuwasako; S Shimamoto; K Igarashi; M Tokashiki; K Kitamura
Journal:  J Hum Hypertens       Date:  2017-03-02       Impact factor: 3.012

Review 7.  Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.

Authors:  Bharathi Upadhya; Dalane W Kitzman
Journal:  Am J Cardiovasc Drugs       Date:  2017-08       Impact factor: 3.571

Review 8.  Nutrition intervention in heart failure: should consumption of the DASH eating pattern be recommended to improve outcomes?

Authors:  Renad Abu-Sawwa; Sandra B Dunbar; Arshed A Quyyumi; Elisabeth L P Sattler
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

9.  Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure.

Authors:  Luay Rifai; Carol Pisano; Janel Hayden; Suela Sulo; Marc A Silver
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

10.  Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet and risk of total and cause-specific mortality: results from the Golestan Cohort Study.

Authors:  Zeinab Mokhtari; Maryam Sharafkhah; Hossein Poustchi; Sadaf G Sepanlou; Masoud Khoshnia; Abdolsamad Gharavi; Amir Ali Sohrabpour; Masoud Sotoudeh; Sanford M Dawsey; Paolo Boffetta; Christian C Abnet; Farin Kamangar; Arash Etemadi; Akram Pourshams; Akbar FazeltabarMalekshah; Farhad Islami; Paul Brennan; Reza Malekzadeh; Azita Hekmatdoost
Journal:  Int J Epidemiol       Date:  2019-12-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.